Open Access
Open access
3 Biotech, volume 8, issue 1, publication number 3

Optimization of a resazurin-based microplate assay for large-scale compound screenings against Klebsiella pneumoniae

Jang Soojin 1
1
 
Antibacterial Resistance Research Laboratory, Discovery Biology Department, Institut Pasteur Korea, Seongnam-si, South Korea
Publication typeJournal Article
Publication date2017-12-07
Journal: 3 Biotech
Quartile SCImago
Q2
Quartile WOS
Q3
Impact factor2.8
ISSN2190572X, 21905738
Biotechnology
Agricultural and Biological Sciences (miscellaneous)
Environmental Science (miscellaneous)
Abstract
A new resazurin-based assay was evaluated and optimized using a microplate (384-well) format for high-throughput screening of antibacterial molecules against Klebsiella pneumoniae. Growth of the bacteria in 384-well plates was more effectively measured and had a > sixfold higher signal-to-background ratio using the resazurin-based assay compared with absorbance measurements at 600 nm. Determination of minimum inhibitory concentrations of the antibiotics revealed that the optimized assay quantitatively measured antibacterial activity of various antibiotics. An edge effect observed in the initial assay was significantly reduced using a 1-h incubation of the bacteria-containing plates at room temperature. There was an approximately 10% decrease in signal variability between the edge and the middle wells along with improvement in the assay robustness (Z′ = 0.99). This optimized resazurin-based assay is an efficient, inexpensive, and robust assay that can quantitatively measure antibacterial activity using a high-throughput screening system to assess a large number of compounds for discovery of new antibiotics against K. pneumoniae.

Citations by journals

1
Combinatorial Chemistry and High Throughput Screening
Combinatorial Chemistry and High Throughput Screening, 1, 8.33%
Combinatorial Chemistry and High Throughput Screening
1 publication, 8.33%
Microbial Drug Resistance
Microbial Drug Resistance, 1, 8.33%
Microbial Drug Resistance
1 publication, 8.33%
PLoS ONE
PLoS ONE, 1, 8.33%
PLoS ONE
1 publication, 8.33%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 1, 8.33%
International Journal of Molecular Sciences
1 publication, 8.33%
Applied Sciences (Switzerland)
Applied Sciences (Switzerland), 1, 8.33%
Applied Sciences (Switzerland)
1 publication, 8.33%
Frontiers in Cellular and Infection Microbiology
Frontiers in Cellular and Infection Microbiology, 1, 8.33%
Frontiers in Cellular and Infection Microbiology
1 publication, 8.33%
Journal of Nanobiotechnology
Journal of Nanobiotechnology, 1, 8.33%
Journal of Nanobiotechnology
1 publication, 8.33%
Toxicology in Vitro
Toxicology in Vitro, 1, 8.33%
Toxicology in Vitro
1 publication, 8.33%
Biochemistry and Biophysics Reports
Biochemistry and Biophysics Reports, 1, 8.33%
Biochemistry and Biophysics Reports
1 publication, 8.33%
Medical Journal of Cell Biology
Medical Journal of Cell Biology, 1, 8.33%
Medical Journal of Cell Biology
1 publication, 8.33%
BIO-PROTOCOL, 1, 8.33%
BIO-PROTOCOL
1 publication, 8.33%
Methods in Enzymology
Methods in Enzymology, 1, 8.33%
Methods in Enzymology
1 publication, 8.33%
1

Citations by publishers

1
2
3
Elsevier
Elsevier, 3, 25%
Elsevier
3 publications, 25%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 2, 16.67%
Multidisciplinary Digital Publishing Institute (MDPI)
2 publications, 16.67%
Bentham Science
Bentham Science, 1, 8.33%
Bentham Science
1 publication, 8.33%
Mary Ann Liebert
Mary Ann Liebert, 1, 8.33%
Mary Ann Liebert
1 publication, 8.33%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 1, 8.33%
Public Library of Science (PLoS)
1 publication, 8.33%
Frontiers Media S.A.
Frontiers Media S.A., 1, 8.33%
Frontiers Media S.A.
1 publication, 8.33%
Springer Nature
Springer Nature, 1, 8.33%
Springer Nature
1 publication, 8.33%
Walter de Gruyter
Walter de Gruyter, 1, 8.33%
Walter de Gruyter
1 publication, 8.33%
Bio-Protocol, 1, 8.33%
Bio-Protocol
1 publication, 8.33%
1
2
3
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Kim H. J., Jang S. Optimization of a resazurin-based microplate assay for large-scale compound screenings against Klebsiella pneumoniae // 3 Biotech. 2017. Vol. 8. No. 1. 3
GOST all authors (up to 50) Copy
Kim H. J., Jang S. Optimization of a resazurin-based microplate assay for large-scale compound screenings against Klebsiella pneumoniae // 3 Biotech. 2017. Vol. 8. No. 1. 3
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s13205-017-1034-9
UR - https://doi.org/10.1007%2Fs13205-017-1034-9
TI - Optimization of a resazurin-based microplate assay for large-scale compound screenings against Klebsiella pneumoniae
T2 - 3 Biotech
AU - Kim, Hyung Jun
AU - Jang, Soojin
PY - 2017
DA - 2017/12/07 00:00:00
PB - Springer Nature
IS - 1
VL - 8
PMID - 29242763
SN - 2190-572X
SN - 2190-5738
ER -
BibTex
Cite this
BibTex Copy
@article{2017_Kim,
author = {Hyung Jun Kim and Soojin Jang},
title = {Optimization of a resazurin-based microplate assay for large-scale compound screenings against Klebsiella pneumoniae},
journal = {3 Biotech},
year = {2017},
volume = {8},
publisher = {Springer Nature},
month = {dec},
url = {https://doi.org/10.1007%2Fs13205-017-1034-9},
number = {1},
doi = {10.1007/s13205-017-1034-9}
}
Found error?